HealthQuest Capital leads $11.8 mln round for Castle Biosciences

Castle Biosciences has closed $11.8 million in financing. HealthQuest Capital led the round with participation from other investors that included Mountain Group Capital and Affiliates and Longfellow Venture Partners. In addition to the funding, Dr. Garheng Kong, managing partner of HealthQuest Capital, has been appointed to Castle Biosciences’ board of directors. Castle Biosciences is a molecular diagnostics and prognostics company.

North AmericaUSBriefs